Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
36.72B | 45.71B | 45.58B | 43.81B | 44.97B | Gross Profit |
12.26B | 14.86B | 15.01B | 13.72B | 14.29B | EBIT |
3.67B | 4.46B | 5.37B | 3.42B | 3.62B | EBITDA |
14.78B | 11.77B | 13.00B | 13.60B | 14.08B | Net Income Common Stockholders |
1.14B | 11.84B | 2.24B | 59.00M | -920.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
10.53B | 18.48B | 14.73B | 11.87B | 19.53B | Total Assets |
144.35B | 155.52B | 154.05B | 155.06B | 168.17B | Total Debt |
54.36B | 61.50B | 67.18B | 66.80B | 69.63B | Net Debt |
48.18B | 49.80B | 59.68B | 60.98B | 56.08B | Total Liabilities |
83.35B | 91.04B | 96.98B | 97.25B | 105.54B | Stockholders Equity |
59.97B | 63.40B | 54.78B | 55.80B | 61.41B |
Cash Flow | Free Cash Flow | |||
9.70B | 13.10B | 13.53B | 11.80B | 12.20B | Operating Cash Flow |
16.56B | 18.05B | 18.08B | 17.21B | 17.38B | Investing Cash Flow |
-6.12B | -379.00M | -6.87B | -9.26B | -8.09B | Financing Cash Flow |
-15.86B | -13.43B | -9.71B | -15.20B | -9.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $59.20B | 10.36 | 36.94% | ― | 0.93% | 16.06% | |
75 Outperform | $184.54B | 10.55 | 18.23% | 6.41% | 0.93% | 56.97% | |
75 Outperform | $128.18B | 8.32 | 18.57% | 3.66% | 1.33% | 7.69% | |
73 Outperform | $192.45B | 16.46 | 11.38% | 4.14% | 0.50% | -12.66% | |
72 Outperform | $264.30B | 22.69 | 19.35% | 1.31% | 5.31% | 38.46% | |
71 Outperform | $23.28B | 9.11 | 4.31% | 7.44% | -24.84% | -74.77% | |
59 Neutral | $13.69B | 6.83 | -3.38% | 3.82% | 2.32% | -34.61% |